Clinical overview
Heart failure is a clinical syndrome caused by structural or functional cardiac abnormality. Diagnosis combines symptoms, signs, natriuretic peptides, ECG and cardiac imaging.
Clinical significance
Phenotype by ejection fraction, aetiology, congestion, rhythm and comorbidity. A normal chest radiograph or absence of peripheral oedema does not exclude heart failure.
Initial assessment
Define symptom onset, haemodynamic stability, rhythm, oxygenation, relevant medicines and previous cardiovascular disease. Obtain a 12-lead ECG and appropriate biomarkers or imaging without delaying treatment of a time-critical presentation.
Diagnostic strategy
Use history, examination, serial testing and targeted imaging. Compare with prior ECGs and imaging where available. A single normal result may not exclude evolving disease, particularly early after symptom onset.
Management principles
Follow the current local and national pathway. Balance ischaemic, thromboembolic, bleeding, renal and haemodynamic risk. Clearly document treatment indication, duration, monitoring and the planned specialist follow-up.
Special populations and comorbidity
Older adults, pregnancy, kidney or liver disease, frailty, active bleeding, cancer and concurrent anticoagulation may alter diagnostic performance and treatment risk. Use specialist advice where evidence is limited or competing risks are substantial.
Clinical pearls
- Trend matters: repeat ECGs, observations and biomarkers when symptoms persist.
- Treat physiological instability before completing routine risk stratification.
- Document why a score or threshold applies to this patient.
Common mistakes
- Relying on one ECG, one troponin or one blood-pressure reading.
- Using a risk score outside its validated population.
- Failing to review renal function, drug interactions and bleeding risk.
- Allowing a reassuring number to override ongoing symptoms or deterioration.
Escalation triggers
Escalate urgently for shock, syncope with instability, ongoing ischaemic pain, malignant arrhythmia, acute pulmonary oedema, rapidly worsening ventricular function, suspected mechanical complication or any need for emergency cardioversion, pacing or reperfusion.
Related MediCalc clinical tools
Related Clinical References
Frequently asked questions
Can this reference replace a specialist pathway?
No. Use the current local cardiology, emergency and medicines pathway.
When should testing be repeated?
Repeat testing when symptoms continue, physiology changes, the first test was early or the result is discordant with the clinical picture.
Key practice points
- Recognise instability first.
- Use serial assessment.
- Match the tool to the population.
- Balance benefit and bleeding or treatment risk.
- Provide a clear follow-up and review plan.